KR
Krystal Biotech
KRYS · NASDAQ
$336.68 -0.69% (-$2.33)
1M +0.28%
Market Cap $9.93B
P/E Ratio 41.10x
Div. Yield -
ROE 19.34%
Bulios Fair Price
$234.79
30.3% downside
Trenutna cena
$336.68
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KRYS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
18 /100
Expensive P/E 41.10x
PEG 0.37x
EV/EBITDA 43.52x
Growth
100 /100
Growing Book val. growth 32.67%
EPS growth N/A
FCF growth N/A
Profitability
100 /100
Strong Gross margin 93.34%
FCF margin 58.52%
Net margin 54.82%
Quality
78 /100
Excellent ROIC 15.34%
Asset turnover 0.29x
ROE 19.34%
Debt
100 /100
Low Debt/Equity 0.01x
Net debt/EBITDA -1.92x
Current ratio 8.32x
Stability
41 /100
Moderate Beta 0.54x
Profitable years 3
EPS volatility 318.68%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KRYS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Krish S. Krishnan
Employees
295
Headquarters
Pittsburgh
Prihajajoči dogodki
02 NOV.
Earnings
Upcoming earnings report